Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abebayehu N Yilma

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Mediators of Inflammation|June 15, 2013
Flavonoid naringenin: a potential immunomodulator for Chlamydia trachomatis inflammationAbebayehu N Yilma, Shree R Singh, Lisa Morici, et al.
International Journal of Nanomedicine|July 25, 2013
Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatisAbebayehu N Yilma, Shree R Singh, Saurabh Dixit, et al.
American Journal of Rhinology & Allergy|March 27, 2010
Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitisJivianne T Lee, Mike Jansen, Abebayehu N Yilma, et al.
Mediators of Inflammation|April 25, 2012
The anti-inflammatory cytokine, interleukin-10, inhibits inflammatory mediators in human epithelial cells and mouse macrophages exposed to live and UV-inactivated Chlamydia trachomatisAbebayehu N Yilma, Shree R Singh, Stacie J Fairley, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2014
Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in miceSaurabh Dixit, Shree R Singh, Abebayehu N Yilma, et al.
International Journal of Nanomedicine|February 13, 2024
PLGA-Chitosan Encapsulated IL-10 Nanoparticles Modulate Chlamydia Inflammation in MiceAbebayehu N Yilma, Rajnish Sahu, Praseetha Subbarayan, et al.
One Health Outlook|June 17, 2026
Zoonotic disease knowledge, attitudes, and livestock biosecurity practices among community members in Ada East District, Ghana: a concurrent mixed-methods studyKirstin P West, Marta A Kisiel, Kristin K Sznajder, et al.
Frontiers in Nutrition|April 18, 2025
Subclinical vitamin A deficiency and associated factors among pregnant women in eastern EthiopiaKedir Teji Roba, Gemechu Asefa, Meseret Belete Fite, et al.
International Journal of Nanomedicine|June 21, 2013
Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccineStacie J Fairley, Shree R Singh, Abebayehu N Yilma, et al.
BMC Cancer|October 17, 2025
Barriers to timely diagnosis and treatment of childhood cancer in Sub-Sahara Africa: a qualitative systematic reviewAbraham Tamirat Gizaw, Indryas Woldie, Abebayehu N Yilma, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Mediators of Inflammation|June 15, 2013
Flavonoid naringenin: a potential immunomodulator for Chlamydia trachomatis inflammationAbebayehu N Yilma, Shree R Singh, Lisa Morici, et al.
International Journal of Nanomedicine|July 25, 2013
Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatisAbebayehu N Yilma, Shree R Singh, Saurabh Dixit, et al.
American Journal of Rhinology & Allergy|March 27, 2010
Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitisJivianne T Lee, Mike Jansen, Abebayehu N Yilma, et al.
Mediators of Inflammation|April 25, 2012
The anti-inflammatory cytokine, interleukin-10, inhibits inflammatory mediators in human epithelial cells and mouse macrophages exposed to live and UV-inactivated Chlamydia trachomatisAbebayehu N Yilma, Shree R Singh, Stacie J Fairley, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2014
Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in miceSaurabh Dixit, Shree R Singh, Abebayehu N Yilma, et al.
International Journal of Nanomedicine|February 13, 2024
PLGA-Chitosan Encapsulated IL-10 Nanoparticles Modulate Chlamydia Inflammation in MiceAbebayehu N Yilma, Rajnish Sahu, Praseetha Subbarayan, et al.
One Health Outlook|June 17, 2026
Zoonotic disease knowledge, attitudes, and livestock biosecurity practices among community members in Ada East District, Ghana: a concurrent mixed-methods studyKirstin P West, Marta A Kisiel, Kristin K Sznajder, et al.
Frontiers in Nutrition|April 18, 2025
Subclinical vitamin A deficiency and associated factors among pregnant women in eastern EthiopiaKedir Teji Roba, Gemechu Asefa, Meseret Belete Fite, et al.
International Journal of Nanomedicine|June 21, 2013
Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccineStacie J Fairley, Shree R Singh, Abebayehu N Yilma, et al.
BMC Cancer|October 17, 2025
Barriers to timely diagnosis and treatment of childhood cancer in Sub-Sahara Africa: a qualitative systematic reviewAbraham Tamirat Gizaw, Indryas Woldie, Abebayehu N Yilma, et al.
Pageof 2